Fundraising Fox
Caldre
1 known investors
Find your way into Caldre
Sign up to see every warm intro you have to Caldre
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Caldre team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CALDRE is a Switzerland-based biotech spin-out developing liver-directed GalNAc-siRNA therapeutics, including its claudin-3 targeting candidate ClagalsiR, to restore bile flow and prevent fibrosis. It aims to treat cholestatic and fibrotic liver diseases such as primary sclerosing cholangitis and primary biliary cholangitis and reduce the need for liver transplantation.
Investors · 1
Kickfund✓ confirmed by CaldreBasel · $950K
How we know: Kickfund's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Caldre do?
- CALDRE is a Switzerland-based biotech spin-out developing liver-directed GalNAc-siRNA therapeutics, including its claudin-3 targeting candidate ClagalsiR, to restore bile flow and prevent fibrosis. It aims to treat cholestatic and fibrotic liver diseases such as primary sclerosing cholangitis and primary biliary cholangitis and reduce the need for liver transplantation.
- Who are Caldre's investors?
- Caldre's investors include Kickfund.